If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.28    -0.03 (-2.33%)
Bid:
1.23
Ask:
1.29
Spread: 0.06 (4.878%)
Market Cap: £30.03m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Total Voting Rights

31 Mar 2010 16:35

RNS Number : 5613J
Provexis PLC
31 March 2010
 



Provexis plc (the "Company")

 

Total Voting Rights Update

 

 

The Company wishes to notify the market of the following:-

 

The Company's issued share capital consists of1,108,081,929 ordinary shares of 0.1 pence each ("Ordinary Shares"), all with voting rights. No shares were held in treasury at the date of this announcement. The total number of current voting rights in the Company is therefore 1,108,081,929.

 

The above figure (1,108,081,929 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company.

 

31 March 2010

 

ENQUIRIES:

 

Provexis plc

Stephen Moon/Ian Ford

Tel +44 (0)1753 752290

Evolution Securities

Bobbie Hilliam/Sam Plumptre

Tel +44 (0)20 7071 4300

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRUAOVRRVAOOAR
Date   Source Headline
28th Feb 20117:00 amRNSDevelopment Agreement with DSM Nutritional Product
8th Feb 20114:35 pmRNSPrice Monitoring Extension
16th Dec 20107:00 amRNSINTERIM RESULTS
9th Dec 20107:00 amRNSNotice of Results
17th Nov 20107:00 amRNSFruitflow wins industry innovation awards
29th Oct 20107:00 amRNSTotal Voting Rights
27th Oct 20104:40 pmRNSSecond Price Monitoring Extn
27th Oct 20104:35 pmRNSPrice Monitoring Extension
14th Oct 20101:38 pmRNSHolding(s) in Company
11th Oct 201011:53 amRNSHolding(s) in Company
4th Oct 20107:00 amRNSIssue of Equity
13th Sep 20104:24 pmRNSHolding(s) in Company
9th Sep 20103:17 pmRNSResult of AGM
9th Sep 20107:00 amRNSAGM Statement
7th Sep 20104:40 pmRNSSecond Price Monitoring Extn
7th Sep 20104:35 pmRNSPrice Monitoring Extension
6th Sep 20104:35 pmRNSPrice Monitoring Extension
13th Aug 20107:00 amRNSAnnual report & accounts and notice of AGM
28th Jul 20104:40 pmRNSSecond Price Monitoring Extn
28th Jul 20104:35 pmRNSPrice Monitoring Extension
26th Jul 201011:35 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
26th Jul 20107:00 amRNSProduct Update
23rd Jul 20104:40 pmRNSSecond Price Monitoring Extn
23rd Jul 20104:35 pmRNSPrice Monitoring Extension
22nd Jul 20104:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20104:35 pmRNSPrice Monitoring Extension
14th Jul 20104:40 pmRNSSecond Price Monitoring Extn
14th Jul 20104:35 pmRNSPrice Monitoring Extension
8th Jul 20104:40 pmRNSSecond Price Monitoring Extn
8th Jul 20104:35 pmRNSPrice Monitoring Extension
28th Jun 20104:40 pmRNSSecond Price Monitoring Extn
28th Jun 20104:35 pmRNSPrice Monitoring Extension
22nd Jun 20107:00 amRNSDraw Down of Funds and Issue of Equity
15th Jun 20104:40 pmRNSSecond Price Monitoring Extn
15th Jun 20104:35 pmRNSPrice Monitoring Extension
10th Jun 20104:40 pmRNSSecond Price Monitoring Extn
10th Jun 20104:35 pmRNSPrice Monitoring Extension
1st Jun 20107:00 amRNSFinal Results
1st Jun 20107:00 amRNSAlliance agreement with DSM Nutritional Products
28th May 20103:20 pmRNSNotice of Results
26th Apr 20107:00 amRNSRe Agreement
21st Apr 20107:00 amRNSChange in major shareholding
21st Apr 20107:00 amRNSNotification of Major Interest in Shares
13th Apr 201012:01 pmRNSHolding(s) in Company
31st Mar 20104:35 pmRNSTotal Voting Rights
31st Mar 20107:00 amRNSPre-close trading update
31st Mar 20107:00 amRNSCompletion of ?25m Equity Financing Facility
9th Mar 20107:00 amRNSTrial Results
18th Feb 201011:30 amRNSHolding(s) in Company
12th Feb 20103:20 pmRNSDirector Shareholdings and Additional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.